Retour au classement

Siemens Aktiengesellschaft (SMAWF)

NEUTRAL
IndustrialsSpecialty Industrial MachineryGermany

Fondamental

62

Prix

$334.00

Capitalisation boursière

$249.04B

Partie 1 · Ce que vaut l'entreprise

Vue d'ensemble

Siemens sells the automation equipment, software and electrical infrastructure that factories, buildings and rail systems run on, plus it majority-owns Siemens Healthineers, a separately listed medical-imaging and diagnostics company. Its factory-automation and infrastructure businesses sell to industrial and construction customers worldwide; its rail unit builds trains and signaling systems for transit operators. The common thread across the divisions is selling equipment and software that customers depend on for years, not months.

Comment l'entreprise gagne de l'argent

Revenue comes mostly from selling hardware and software for factory automation, building systems and rail equipment, often bundled with long-term service and maintenance contracts that generate recurring income after the initial sale. Siemens Healthineers, consolidated into group results even though it trades as its own stock, adds revenue from selling and servicing imaging machines and diagnostic equipment to hospitals, a business with its own multi-year sales and service cycle.

Chiffre d'affaires par segment

Siemens Healthineers29.6%

Majority-owned, separately listed medical technology business selling imaging and diagnostic equipment to hospitals; Siemens' largest segment.

Smart Infrastructure29.2%

Electrical products, building automation and grid technology sold to construction and utility customers.

Digital Industries22.6%

Factory automation hardware and industrial software used to design and run manufacturing plants; the segment that declined in fiscal 2025.

Mobility15.7%

Trains, rail infrastructure and signaling systems sold to public transit operators and railways.

Avantage concurrentiel

Coûts de changement · Étroit

Once a factory or hospital is built around Siemens automation systems, imaging equipment or signaling technology, replacing it means retraining staff and requalifying processes, which discourages switching for years. The advantage is narrow rather than wide because each division faces capable global rivals — Schneider Electric and Rockwell in automation, GE Healthcare and Philips in imaging, Alstom in rail — that win contracts on price and features.

Ce qui stimule la demande

Cyclique

Industrial automation spending tracks factory investment cycles, which slow when manufacturers cut capital budgets in a downturn, and rail and infrastructure orders depend on large, lumpy public and private capital projects. Healthineers is the exception: hospital spending on imaging and diagnostics is comparatively steady, which softens the swings from the more industrial divisions.

Les arguments en faveur

Buyers point to steady growth at Smart Infrastructure and Mobility, resilient demand for Healthineers' hospital equipment, and long-lived customer relationships across the automation business as reasons the group can keep compounding revenue even as one division has a soft year.

Les arguments contre

Sellers worry that Digital Industries' decline signals weaker manufacturing capital spending that could spread to other divisions in a broader downturn, and that running four largely unrelated global businesses, one of them a separately listed subsidiary, makes the group harder to value and manage than a set of focused competitors.

Written by the editors, published on 18 août 2026

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Bilan & Liquidités

Chiffre d'affaires

$81.12B

12 derniers mois (au 30/06/2026)

Résultat net

$7.95B

12 derniers mois (au 30/06/2026)

Flux de trésorerie libre

$6.50B

Capitaux propres totaux

$72.70B

Passif total

$49.92B

Ratio de liquidité général

1.44

Couverture des intérêts

-

Dette/EBITDA

3.99

Bénéfice par action

Chiffre d'affaires & Résultat net

Flux de trésorerie libre

Décomposition du résultat

État historique

Marges dans le temps

La dette dans le temps

Le poids de la dette

Grille de la croissance

Croissance — Chiffre d'affaires

Estimation de la juste valeur

Surévalué

Juste valeur

$257.48

Prix actuel

$334.00

Marge de sécurité

-29.7%

Fourchette de juste valeur

$167.36 - $347.59

Méthodes d'estimation

Analyst Target:-
DCF:$226.53
PE-based:$265.74
Graham Growth:$492.96
EPV:$90.04
Consensus des analystes:Acheter (23B / 6H / 2S)
Dernière surprise sur les résultats:+10.97%

Indicateurs de valorisation

Ratio P/E

27.93

ROE

12.5%

Ratio P/B

3.43

P/FCF

38.29

Marge brute

39.4%

ROIC

7.8%

Radar de rentabilité

Value Creation (Economic Moat)

ROIC

7.8%

WACC

9.7%

ROIC − WACC

-1.9 pp

ROIC is below the cost of capital — the company is destroying value for every dollar invested.

Critères d'analyse fondamentale

Réussi (13)

  • Price CAGR 10.34%
  • ROIC 7.8%
  • Gross Margin 39.4%
  • Debt/Equity ratio
  • Positive Free Cash Flow
  • Current Ratio
  • Debt/EBITDA
  • ROE 12.2%
  • Revenue Growth 5Y 7.4%
  • Analyst Consensus 74% Buy
  • PEG Ratio 1.37
  • Earnings Quality (OCF/NI) 1.49
  • Net Margin Trend 12.2% vs 10.9%

Échoué (6)

  • P/FCF 38.29
  • P/B Ratio 3.43
  • CapEx intensity
  • DCF valuation (Overvalued)
  • Earnings Surprise avg 0.2%
  • Piotroski F-Score 2/9

Indisponible (8)

  • EPS data insufficient
  • Dividend Payout NaN%
  • Operating Margin NaN%
  • Interest Coverage
  • Return on Tangible Assets
  • Low reliance on intangibles
  • Price below Graham Number
  • Share Dilution (missing shares data)

Score F de Piotroski

2/9

Préoccupations financières sérieuses

score
criteria

Qualité des bénéfices

1.49

Qualité élevée : bénéfices soutenus par la trésorerie

Dilution du capital

-

Rachat d'actions. Favorable aux actionnaires

Gouvernance

Équipe dirigeante

NomTitreÂge
Dr. Roland Busch Dipl.Phys.President, CEO & Chairman of Management Board61
Ms. Veronika BienertCFO & Member of Management Board52
Mr. Cedrik NeikeCEO of Digital Industries & Member of Managing Board52
Ms. Judith WieseChief People & Sustainability Officer and Member of Managing Board54
Dr. Peter Koerte Ph.D.CTO, CEO of Siemens Smart Infrastructure, Chief Strategy Officer & Member of Management Board50
Dr. Ralf P. ThomasSpecial Advisor64
Dr. Andreas Christian HoffmannGeneral Counsel, Head of the Legal & Compliance Department61
Mr. Hanno KunkelChief Compliance Officer and Head of the Global Compliance Organization & Human Rights Officer50
Ms. Christiane Ribeiro Guimaraes HoferGlobal Head of Communications47
Dr. Jochen Schmitz Ph.D.Chief Financial Officer of Siemens Healthineers59

Risque d'audit

1

Risque du conseil

5

Risque de rémunération

1

Risque droits des actionnaires

1

Partie 2 · Le prix et le moment d'entrer

Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.

Latest News

Recent headlines for SMAWF, sourced from Markets Gazette.

No recent news for SMAWF.